Nordicus Partners Corporation
A business accelerator and holding company that helps life-sciences firms from the Nordic countries break into the U.S. market, offering corporate finance, partnerships, and growth strategy. It began in 1993 as Cardiotech International, a subsidiary of PolyMedica, later trading as AdvanSource Biomaterials and EKIMAS before rebranding as Nordicus Partners in 2023. The name "Nordicus" nods to its Nordic focus—it scouts promising Scandinavian ventures and helps them scale stateside.
Bought 6.47M · Sold 7.67M
Bought 206.5K · Sold 7.5K
Sold 500.0K
Bought 9.38M · Sold 292.5K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Alteral Therapeutics ApS10% owner · 1 transaction | — | 5.30Mas of Nov 2024 | — | — | — |
| GK Partners ApS10% owner · 48 transactions | — | 3.26Mas of Aug 2025 | — | 6.47M | 7.67M |
| AC Nordic ApS10% owner · 10 transactions | — | 3.12Mas of Jul 2025 | — | 206.5K | 7.5K |
| ABCHill Holding ApS10% owner · 2 transactions | — | 916.3Kas of Nov 2024 | — | — | — |
| Oerbekker HenrikFormer 10% shareholder · 1 transaction | — | 278.6Kas of Jan 2023 | — | — | 500.0K |
| Rouf HenrikChief Executive Officer · 32 transactions | — | 16.0Kas of Aug 2025 | — | 9.38M | 292.5K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: +7.59M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.